AI-Designed Drugs by DeepMind Spinoff Headed to Human Trials

Isomorphic Labs, a DeepMind spinoff, is advancing a pipeline of AI-designed new medicines toward human trials, marking a major milestone in artificial intelligence applied to healthcare. This development represents a paradigm shift in drug discovery, potentially accelerating the creation of treatments for complex diseases. The success of these trials will determine the future role of AI in mainstream medical research.